Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier
- Vol. 51 (1) , 81-86
- https://doi.org/10.1016/s0360-3016(01)01576-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation therapy oncology group (RTOG) 97-13International Journal of Radiation Oncology*Biology*Physics, 2000
- Biafine Applied on Human Epidermal Wounds Is Chemotactic for Macrophages and Increases the IL1/IL6 RatioSkin Pharmacology and Physiology, 1997
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an UpdateJNCI Journal of the National Cancer Institute, 1996
- Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicityInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Ten year results of conservative surgery and irradiation for stage I and II breast cancerInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Acute and late effects of multimodal therapy on normal tissuesCancer, 1977
- Adriamycin and Enhanced Radiation Reaction in Normal Esophagus and SkinAnnals of Internal Medicine, 1976